These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 12495432
1. Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain. Boucard AA, Sauvé SS, Guillemette G, Escher E, Leduc R. Biochem J; 2003 Mar 15; 370(Pt 3):829-38. PubMed ID: 12495432 [Abstract] [Full Text] [Related]
2. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites. Holleran BJ, Beaulieu ME, Proulx CD, Lavigne P, Escher E, Leduc R. Biochem J; 2007 Feb 15; 402(1):51-61. PubMed ID: 17064254 [Abstract] [Full Text] [Related]
3. Transmembrane domain V of the endothelin-A receptor is a binding domain of ETA-selective TTA-386-derived photoprobes. Tessier S, Boivin S, Aubin J, Lampron P, Detheux M, Fournier A. Biochemistry; 2005 May 31; 44(21):7844-54. PubMed ID: 15909998 [Abstract] [Full Text] [Related]
4. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Liu Q, Pong SS, Zeng Z, Zhang Q, Howard AD, Williams DL, Davidoff M, Wang R, Austin CP, McDonald TP, Bai C, George SR, Evans JF, Caskey CT. Biochem Biophys Res Commun; 1999 Dec 09; 266(1):174-8. PubMed ID: 10581185 [Abstract] [Full Text] [Related]
5. Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor. Holleran BJ, Domazet I, Beaulieu ME, Yan LP, Guillemette G, Lavigne P, Escher E, Leduc R. Biochem Pharmacol; 2009 Apr 15; 77(8):1374-82. PubMed ID: 19426676 [Abstract] [Full Text] [Related]
6. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Ohlstein EH, Bergsma DJ, Douglas SA. Nature; 1999 Sep 16; 401(6750):282-6. PubMed ID: 10499587 [Abstract] [Full Text] [Related]
7. Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay. Brkovic A, Hattenberger A, Kostenis E, Klabunde T, Flohr S, Kurz M, Bourgault S, Fournier A. J Pharmacol Exp Ther; 2003 Sep 16; 306(3):1200-9. PubMed ID: 12807997 [Abstract] [Full Text] [Related]
8. Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Mori M, Sugo T, Abe M, Shimomura Y, Kurihara M, Kitada C, Kikuchi K, Shintani Y, Kurokawa T, Onda H, Nishimura O, Fujino M. Biochem Biophys Res Commun; 1999 Nov 16; 265(1):123-9. PubMed ID: 10548501 [Abstract] [Full Text] [Related]
9. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. Wilczynski A, Wang XS, Joseph CG, Xiang Z, Bauzo RM, Scott JW, Sorensen NB, Shaw AM, Millard WJ, Richards NG, Haskell-Luevano C. J Med Chem; 2004 Apr 22; 47(9):2194-207. PubMed ID: 15084118 [Abstract] [Full Text] [Related]
10. Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II. Boivin S, Ségalas-Milazzo I, Guilhaudis L, Oulyadi H, Fournier A, Davoust D. Peptides; 2008 May 22; 29(5):700-10. PubMed ID: 18423797 [Abstract] [Full Text] [Related]
11. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist. Chatenet D, Dubessy C, Boularan C, Scalbert E, Pfeiffer B, Renard P, Lihrmann I, Pacaud P, Tonon MC, Vaudry H, Leprince J. J Med Chem; 2006 Nov 30; 49(24):7234-8. PubMed ID: 17125276 [Abstract] [Full Text] [Related]
12. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Elshourbagy NA, Douglas SA, Shabon U, Harrison S, Duddy G, Sechler JL, Ao Z, Maleeff BE, Naselsky D, Disa J, Aiyar NV. Br J Pharmacol; 2002 May 30; 136(1):9-22. PubMed ID: 11976263 [Abstract] [Full Text] [Related]
13. Photolabeling study of the ligand binding domain of natriuretic peptide receptor A: development of a model. Jossart C, Coupal M, McNicoll N, Fournier A, Wilkes BC, De Léan A. Biochemistry; 2005 Feb 22; 44(7):2397-408. PubMed ID: 15709752 [Abstract] [Full Text] [Related]
14. Structure-activity relationships of urotensin II and URP. Leprince J, Chatenet D, Dubessy C, Fournier A, Pfeiffer B, Scalbert E, Renard P, Pacaud P, Oulyadi H, Ségalas-Milazzo I, Guilhaudis L, Davoust D, Tonon MC, Vaudry H. Peptides; 2008 May 22; 29(5):658-73. PubMed ID: 17931747 [Abstract] [Full Text] [Related]
15. Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11). Marzola E, Camarda V, Batuwangala M, Lambert DG, Calo' G, Guerrini R, Trapella C, Regoli D, Tomatis R, Salvadori S. Peptides; 2008 May 22; 29(5):674-9. PubMed ID: 17822806 [Abstract] [Full Text] [Related]
16. Temperature-dependent variations of ligand-receptor contact points in hAT(1). Arsenault J, Renaud MP, Clément M, Fillion D, Guillemette G, Leduc R, Lavigne P, Escher E. J Pept Sci; 2007 Sep 22; 13(9):575-80. PubMed ID: 17600857 [Abstract] [Full Text] [Related]
17. Unraveling the active conformation of urotensin II. Carotenuto A, Grieco P, Campiglia P, Novellino E, Rovero P. J Med Chem; 2004 Mar 25; 47(7):1652-61. PubMed ID: 15027856 [Abstract] [Full Text] [Related]
18. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling. Dong M, Liu G, Pinon DI, Miller LJ. Biochemistry; 2005 May 03; 44(17):6693-700. PubMed ID: 15850403 [Abstract] [Full Text] [Related]
19. Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography. Disa J, Floyd LE, Edwards RM, Douglas SA, Aiyar NV. Peptides; 2006 Jun 03; 27(6):1532-7. PubMed ID: 16290260 [Abstract] [Full Text] [Related]
20. New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide. Grieco P, Carotenuto A, Campiglia P, Gomez-Monterrey I, Auriemma L, Sala M, Marcozzi C, d'Emmanuele di Villa Bianca R, Brancaccio D, Rovero P, Santicioli P, Meini S, Maggi CA, Novellino E. J Med Chem; 2009 Jul 09; 52(13):3927-40. PubMed ID: 19432421 [Abstract] [Full Text] [Related] Page: [Next] [New Search]